Zymeworks (ZYME) Receivables - Other (2022 - 2026)
Zymeworks' (ZYME) quarterly Receivables - Other came in at $1.6 million in Q1 2026, up 688.83% year-on-year from $197000.0 in Q1 2025, and down 43.53% quarter-over-quarter from $2.8 million in Q4 2025.
Zymeworks (ZYME) Receivables - Other (2022 - 2026) Analysis & Trends
Zymeworks has disclosed Receivables - Other across 5 years of filings, most recently posting $1.6 million for Q1 2026.
- Receivables - Other for Q1 2026 came in at $1.6 million, up 688.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.6 million (up 688.83% YoY), and the FY2025 annual result was $2.8 million, up 2652.0% from the prior year.
- Receivables - Other came in at $1.6 million for Q1 2026 at Zymeworks, down from $2.8 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $3.0 million in Q3 2022 to a low of $100000.0 in Q4 2024.
- The 5-year median for Receivables - Other is $1.6 million (2026), against an average of $1.7 million.
- Across the five-year window, Receivables - Other surged 2652.0% in 2025 and jumped 688.83% in 2026, its largest moves.
- Zymeworks' Receivables - Other stood at $3.0 million in 2022, then changed by 0.0% to $3.0 million in 2023, then slumped by 96.67% to $100000.0 in 2024, then soared by 2652.0% to $2.8 million in 2025, then plunged by 43.53% to $1.6 million in 2026.
- The last three Receivables - Other figures came in at $1.6 million (Q1 2026), $2.8 million (Q4 2025), and $971000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Zymeworks | 1.73 Bn | 1.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.55 Mn |
| Mar 31, 2026 | 1.55 Mn |
| Dec 31, 2025 | 2.75 Mn |
| Dec 31, 2025 | 2.75 Mn |
| Sep 30, 2025 | 971,000.00 |
| Sep 30, 2025 | 971,000.00 |
| Jun 30, 2025 | 569,000.00 |
| Jun 30, 2025 | 569,000.00 |
| Mar 31, 2025 | 197,000.00 |
| Mar 31, 2025 | 197,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Mar 31, 2023 | 3.00 Mn |
| Mar 31, 2023 | 3.00 Mn |
| Dec 31, 2022 | 3.00 Mn |
| Dec 31, 2022 | 3.00 Mn |
| Sep 30, 2022 | 3.00 Mn |
| Sep 30, 2022 | 3.00 Mn |